These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1646993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines.
    Totpal K, Aggarwal BB.
    Cancer Res; 1991 Aug 15; 51(16):4266-70. PubMed ID: 1651157
    [Abstract] [Full Text] [Related]

  • 6. In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII).
    Wu PC, Alexander HR, Huang J, Hwu P, Gnant M, Berger AC, Turner E, Wilson O, Libutti SK.
    Cancer Res; 1999 Jan 01; 59(1):205-12. PubMed ID: 9892208
    [Abstract] [Full Text] [Related]

  • 7. Biology of tumor necrosis factor-alpha- implications for psoriasis.
    Schottelius AJ, Moldawer LL, Dinarello CA, Asadullah K, Sterry W, Edwards CK.
    Exp Dermatol; 2004 Apr 01; 13(4):193-222. PubMed ID: 15086336
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor: receptors and inhibitors.
    Loetscher H, Steinmetz M, Lesslauer W.
    Cancer Cells; 1991 Jun 01; 3(6):221-6. PubMed ID: 1654969
    [Abstract] [Full Text] [Related]

  • 9. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J, Hofsli E, Espevik T, Austgulen R.
    Nat Immun Cell Growth Regul; 1988 Jun 01; 7(5-6):266-79. PubMed ID: 3146697
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF, Erff M, Ashkenazi A.
    Clin Cancer Res; 2001 May 01; 7(5):1362-9. PubMed ID: 11350907
    [Abstract] [Full Text] [Related]

  • 19. Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
    Broudy VC, Harlan JM, Adamson JW.
    J Immunol; 1987 Jun 15; 138(12):4298-302. PubMed ID: 3495589
    [Abstract] [Full Text] [Related]

  • 20. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
    Kost ER, Mutch DG, Herzog TJ.
    Gynecol Oncol; 1999 Mar 15; 72(3):392-401. PubMed ID: 10053112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.